Restart Life Sciences Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

OTCPK:NMLS.F Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
25 Mar 26	BuyUS$906	Steve Loutskou	Individual	12,500	US$0.072
20 Mar 26	BuyUS$1,494	Steve Loutskou	Individual	20,500	US$0.073
17 Mar 26	BuyUS$42,709	Khavita Harrycharran	Individual	650,000	US$0.066
10 Mar 26	BuyUS$6,520	Steve Loutskou	Individual	88,500	US$0.074
10 Dec 25	BuyUS$144,740	Khavita Harrycharran	Individual	1,813,808	US$0.087
18 Nov 25	SellUS$142,820	Steve Loutskou	Individual	2,000,000	US$0.071

Insider Trading Volume

Insider Buying: NMLS.F insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of NMLS.F?
Owner Type	Number of Shares	Ownership Percentage
Institutions	572,316	0.966%
Individual Insiders	7,130,689	12%
General Public	51,549,349	87%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 78.3%.

Top Shareholders

Top 6 shareholders own 13% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
5.15%	Steve Loutskou	3,049,011	US$199.1k	4.15%	no data
4.16%	Khavita Harrycharran	2,463,808	US$160.9k	35.8%	no data
1.44%	Derek Lloyd Ivany	855,870	US$55.9k	0%	no data
1.29%	Rebecca Hudson	762,000	US$49.8k	19.6%	no data
0.76%	General Research GmbH	452,316	US$29.5k	0%	6.42%
0.2%	JJ Wolf Investments Ltd.	120,000	US$7.8k	0%	100.0%

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2026/04/15 14:29
End of Day Share Price	2026/04/06 00:00
Earnings	2025/09/30
Annual Earnings	2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Restart Life Sciences Corp. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.